SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban.

Kim, Y-H; Shim, J; Tsai, C-T; Wang, C-C; Vilela, G; Muengtaweepongsa, S; Kurniawan, M; Maskon, O; Hsu, LF; Nguyen, TH; et al. Kim, Y-H; Shim, J; Tsai, C-T; Wang, C-C; Vilela, G; Muengtaweepongsa, S; Kurniawan, M; Maskon, O; Hsu, LF; Nguyen, TH; Sim, K; Camm, AJ (2019) The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban. Chest, 155 (6). pp. 1309-1311. ISSN 1931-3543 https://doi.org/10.1016/j.chest.2019.03.036
SGUL Authors: Camm, Alan John

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (62kB)
Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: 1103 Clinical Sciences, Respiratory System
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Chest
ISSN: 1931-3543
Language: eng
Dates:
DateEvent
June 2019Published
4 June 2019Published Online
7 March 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 31174652
Web of Science ID: WOS:000470109900046
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110973
Publisher's version: https://doi.org/10.1016/j.chest.2019.03.036

Actions (login required)

Edit Item Edit Item